The cluster is too small to signal a change in fundamentals. Monitor for any >$8M insider sales (0.1% of market cap) that would be material. The prior 30-day insider activity of $1.1M in total sales also remains below the threshold.
PCVX drugs
PCVX drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 7 $60.67entry
- T+1 · 4mo ago −3.23%α −2.92% · $58.71
- T+5 · 4mo ago −7.35%α −7.90% · $56.21
- T+20 · 4mo ago −11.77%α −13.10% · $53.53
- T+60 · 7w ago −6.21%α −8.21% · $56.90
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two C-suite insiders at Vaxcyte (PCVX) sold shares worth $478K in the past week, but the amount is negligible relative to the $8.4B market cap (0.006%). The trades are routine option exercises and small share sales, not indicative of a bearish view.
Key Financial Metrics
Key Facts
- President and CFO Andrew Guggenhime sold 7,900 shares for $452K on July 6, 2026.
- COO Jim Wassil sold 456 shares for $26K on July 1, 2026.
- Total open-market sales of $478K represent ~0.006% of market cap, well below the 0.1% materiality threshold.
- Both transactions followed derivative exercises (non-cash events), typical for tax withholding and profit-taking.
Financial Impact
Insider sales of $478K are trivial relative to $8.4B market cap.
Risk Factors
- Insider selling could accelerate if the stock continues to rise, but the current magnitude is routine.
- No other recent filings (e.g., earnings, restatements) to contextualize the sales, treat as standalone liquidity events.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PCVX-1783382471838 |
Track record
29 reports on PCVX
5 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +10.87% at T+5 after the Oct 8, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $62.40 Now $63.37 +1.55% settles Dec 15
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $64.69 Now $63.37 −2.04% settles Dec 11
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $63.89 Now $63.37 −0.81% settles Dec 7
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $63.89 Now $63.37 −0.81% settles Dec 7
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $61.92 Now $63.37 +2.34% settles Dec 4
- Nov 4, 202612d ago 8-K Neutral 5/10 Entry $61.92 Now $63.37 +2.34% settles Dec 4
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $60.81 Now $63.37 +4.21% settles Dec 2
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $60.81 Now $63.37 +4.21% settles Dec 2
- Oct 9, 20265w ago 8-K Bearish 6/10 Entry $70.65 to $67.53 Now $63.37 +10.30% ▲ +4.42% +1.15% vs SPY
- Oct 8, 20265w ago 424B5 Bearish 6/10 Entry $71.38 to $63.89 Now $63.37 +11.22% ▲ +10.49% +4.93% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers